Related Experiment Videos
Translational discrimination of mRNAs coding for human insulin-like growth factor II
F C Nielsen1, S Gammeltoft, J Christiansen
1Department of Clinical Chemistry, Bispebjerg Hospital, Copenhagen NV, Denmark.
Abstract:
Sucrose gradient and Northern analyses were used to study the translational status of endogenous multiple mRNAs encoding the prepropeptide for human insulin-like growth factor II. The results showed that a minor 4.8-kilobase mRNA was exclusively engaged in the synthesis of the prepropeptide on membrane-bound polysomes, whereas a major 6.0-kilobase mRNA was present in a cytoplasmic particle which was stable in EDTA. We conclude that the translational discrimination between the mRNAs is dictated by their different 5'-untranslated regions.
Insights
Two messenger RNA (mRNA) variants for human insulin-like growth factor II (IGF-II) show distinct translational roles. A minor 4.8-kb mRNA directs peptide synthesis on bound ribosomes, while a major 6.0-kb mRNA resides in cytoplasmic particles, differing due to their 5' untranslated regions.
Area of Science:
- Molecular Biology
- Gene Expression Regulation
- Protein Synthesis
Background:
- Insulin-like growth factor II (IGF-II) is crucial for fetal development and implicated in certain cancers.
- Multiple messenger RNA (mRNA) transcripts can encode the same protein, potentially leading to differential regulation.
- Understanding mRNA translational control is key to comprehending protein production levels.
Purpose of the Study:
- To investigate the translational status and cellular localization of different human IGF-II prepropeptide messenger RNA (mRNA) variants.
- To determine how distinct mRNA forms contribute to the synthesis of IGF-II.
- To elucidate the regulatory mechanisms governing IGF-II mRNA translation.
Main Methods:
- Sucrose gradient centrifugation was employed to separate cellular components based on size and density.
- Northern blot analysis was utilized to detect and quantify specific mRNA species.
- Analysis focused on the association of mRNA with polysomes (sites of active protein synthesis) and other cytoplasmic particles.
Main Results:
- A minor 4.8-kilobase (kb) mRNA encoding human IGF-II prepropeptide was found exclusively on membrane-bound polysomes, indicating active translation.
- A major 6.0-kb mRNA variant was identified in stable cytoplasmic particles, resistant to EDTA treatment which typically disassembles ribosomes.
- These findings suggest differential localization and translational engagement based on mRNA size.
Conclusions:
- The distinct translational fates of the 4.8-kb and 6.0-kb human IGF-II mRNAs are determined by differences in their 5'-untranslated regions (5'-UTRs).
- The 5'-UTR acts as a critical regulatory element controlling mRNA localization and translation initiation.
- This translational discrimination provides a mechanism for fine-tuning IGF-II production during development or in disease states.